Hessekiel Jeffrey

Hessekiel Jeffrey is listed in filings as EVP at Exelixis Inc. This profile follows SEC Form 4 activity through Mar 17, 2026, including sale activity. Recent filings connect the profile to Exelixis Inc (EXEL) and Cytokinetics, Incorporated - Common Stock (CYTK). The current snapshot covers public activity from Aug 9, 2024 to Mar 17, 2026. Reported amounts are shown as $2.1M to $515.8K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.